Comparison of two commercial molecular assays to a laboratory-developed molecular assay for diagnosis of Clostridium difficile infection |
| |
| Authors: | Karre Tess Sloan Lynne Patel Robin Mandrekar Jayawant Rosenblatt Jon |
| |
| Affiliation: | Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. teresa.karre@dhha.org |
| |
| Abstract: | ![]()
We compared two commercial PCR assays, the Prodesse ProGastro CD assay and the BD GeneOhm Cdiff assay, with a laboratory-developed Clostridium difficile toxin PCR assay with previously established performance characteristics. Results of all methods were in agreement for 333 (96%) of 346 stool specimens. No significant difference in performance among the assays was found (P values, >0.05). |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
